X-38411901-T-G
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000531.6(OTC):c.907T>G(p.Cys303Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C303Y) has been classified as Pathogenic.
Frequency
Consequence
NM_000531.6 missense
Scores
Clinical Significance
Conservation
Publications
- ornithine carbamoyltransferase deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.907T>G | p.Cys303Gly | missense_variant | Exon 9 of 10 | ENST00000039007.5 | NP_000522.3 | |
OTC | NM_001407092.1 | c.907T>G | p.Cys303Gly | missense_variant | Exon 11 of 12 | NP_001394021.1 | ||
OTC | XM_017029556.2 | c.*40T>G | downstream_gene_variant | XP_016885045.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Cys303 amino acid residue in OTC. Other variant(s) that disrupt this residue have been observed in individuals with OTC-related conditions (PMID: 9266388, 9452049), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt OTC protein function. ClinVar contains an entry for this variant (Variation ID: 97357). This missense change has been observed in individuals with clinical features of ornithine transcarbamylase deficiency (PMID: 11793468; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces cysteine, which is neutral and slightly polar, with glycine, which is neutral and non-polar, at codon 303 of the OTC protein (p.Cys303Gly). -
Variant summary: OTC c.907T>G (p.Cys303Gly) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 183267 control chromosomes (gnomAD). c.907T>G has been reported in individuals affected with Ornithine Transcarbamylase Deficiency (Tuchman_2002, Labcorp Genetics (formerly Invitae)). These data indicate that the variant may be associated with disease. Publications report experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 10%-<30% of normal activity (Scharre_2022). The following publications have been ascertained in the context of this evaluation (PMID: 11793468, 37146589, 36217298). ClinVar contains an entry for this variant (Variation ID: 97357). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at